BRK-B vs ERC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
ERC presents a compelling deep-value opportunity, characterized by a stable Piotroski F-Score of 6/9 and a current price ($9.19) that trades significantly below both its Graham Number ($14.73) and estimated Intrinsic Value ($28.32). While the technical trend is currently bearish (0/100), the fundamental valuation metrics—including a P/B of 0.91 and a low P/E of 9.57—suggest the asset is heavily undervalued. Strong earnings growth of 47.7% offsets the slight decline in revenue, though the high dividend payout ratio requires monitoring.
Compare Another Pair
Related Comparisons
BRK-B vs ERC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Allspring Multi-Sector Income Fund (ERC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.